Results 111 to 120 of about 42,559 (244)

An Epileptic Girl With Erotomania Using Carbamazepine|Resistant to Treatment and Challenge of Starting Clozapine

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT The management of treatment‐resistant erotomania in patients with epilepsy requires a cautious pharmacological approach. This case demonstrates that replacing carbamazepine with valproic acid enabled the safe initiation of clozapine, resulting in resolution of erotomanic delusions while maintaining effective seizure control.
Fateme Roham, Shaghayegh Mohammadghasemi, Reza Bidaki, Iman Hasanabadi, Ahmad Shamsi   +4 more
wiley   +1 more source

Association Discovery Approach in Healthcare Big Data to Identify Drug Safety and Drug Repurposing Signals

Clinical Pharmacology &Therapeutics, Volume 119, Issue 1, Page 228-240, January 2026.
Data science approaches have been increasingly implemented in healthcare big data to evaluate the safety and effectiveness of drugs. Association discovery is a data mining approach that finds potentially associated elements in high‐dimensional data. We present a novel implementation of the association discovery approach in longitudinal healthcare data ...
George S. Q. Tan, Lynn Miller, Sam Wade, Jenni Ilomäki, Dickson Lukose, Jia Rong, Geoffrey I. Webb   +6 more
wiley   +1 more source

COVID‐19 Infection Changed P300 Latency in Patients With Psychosis: A Retrospective Cohort Study

Health Science Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Background and Aims The COVID‐19 pandemic raises concerns about neurological impacts on individuals with mental health conditions, particularly cognitive function. P300 event‐related potential (ERP) latency is a validated neurophysiological marker of attention and working memory.
Xiaofeng Jiang, Shunqi Qiu, Weiwei Wang, Siwen Xu, Shengpang Wang   +4 more
wiley   +1 more source

A Rational Approach to Pharmacotherapy in Pregnancy

The Journal of Clinical Pharmacology, Volume 66, Issue 1, January 2026.
Abstract Most pregnant individuals are exposed to at least one medication, whether prescription or over the counter, during pregnancy. Despite the ubiquity of medication use in pregnancy, there remains no standardized framework to guide clinicians in selecting the most appropriate pharmacotherapy that balances maternal needs with fetal safety. This gap
Gregory W. Kirschen, Kevin Watt, Ahizechukwu C. Eke   +2 more
wiley   +1 more source

Reduction in costs of inpatient stay associated with clozapine treatment: A retrospective study [PDF]

, 1998
Catherine Lyons, Paul C. McDonald, JE Maitland, J D Watson, DJ King, MF Mannion   +5 more
openalex   +1 more source

Development and Validation of a Multigene Panel for Pharmacogenomics Testing Using Next‐Generation Sequencing for Routine Clinical Practice

Clinical and Translational Science, Volume 19, Issue 1, January 2026.
ABSTRACT Pharmacogenomics (PGx) is a rapidly evolving field that aims to personalize medicine by identifying genetic variations that influence drug response. While next‐generation sequencing (NGS)–based applications are not yet widely adopted in clinical routine, this study aimed to validate 9 genes of the NGS‐based Ion AmpliSeq Pharmacogenomics Panel ...
Yaowaluck Hongkaew, Pattapon Kunadirek, Montinee Sangtian, Prangwan Pateetin, Srichan Bunlungsup, Wipa Panmontha, Sornsawan Kawprasertsri, Tanawat Khunlertkit   +7 more
wiley   +1 more source

Clozapine-induced massive hematemesis: A rare case report

, 2019
Javed Ather Siddiqui, Shazia Farheen Qureshi, YousefBin Ahmed Shawosh   +2 more
openalex   +1 more source

Electroconvulsive therapy combined with clozapine in the management of ultra-resistant schizophrenia [PDF]

, 2021
S. Khouadja, O. Charaa, R. Ben Soussia, L. Zarrouk   +3 more
openalex   +1 more source

An open‐label study on ulotaront's effects on insulin‐glucose regulation in schizophrenia patients with metabolic syndrome and prediabetes: Part I

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 103-111, January 2026.
Abstract Aims Ulotaront is an investigational trace amine‐associated receptor 1 (TAAR1) agonist demonstrated to slow gastric emptying in schizophrenia patients with metabolic syndrome (MetSyn) and prediabetes type 2. Here we evaluate the effects of ulotaront on glucose‐insulin dynamics in schizophrenia patients with MetSyn and prediabetes.
Snezana Milanovic, Robert Lew, Kuangnan Xiong, Emily Casavant, Gerard Galluppi, Yu‐Luan Chen, Yongquan Lai, Manu Chakravarthy, Clay Dehn, Kenneth Koblan, Seth C. Hopkins   +10 more
wiley   +1 more source

Heartfelt intervention: A role for PVN oxytocin neurons in the prediabetic heart

The Journal of Physiology, EarlyView.
Grace K. Nielsen, Reesa M. Wilcox, Han‐Jun Wang   +2 more
wiley   +1 more source